ASPREE Project News
Aspirin overview: history, use, secondary prevention and primary prevention
Weekly Dose: aspirin, the pain and fever reliever that prevents heart attacks, strokes and maybe cancer Aspirin...
Dementia Awareness Month
Reminding people impacted by dementia that they are not alone ASPREE warmly welcomes and thanks Ann...
ASPREE participant’s 70 year commitment to footwear
Pease’s well trodden trade With thanks to North West Tasmanian ASPREE participant, Mr John Pease, we are...
Can aspirin prevent depression in older adults?
ASPREE investigates effect of aspirin on depression Many may have read with interest an article on the ASPREE-D...
ASPREE-G (Genomics) – genetics research in older adults
What is genetic research? In the last edition of ‘The Tablet’ newsletter we discussed genetic research...
ASPREE and US aspirin guidelines
Researchers cite ASPREE to inform aspirin guidelines in older adults International researchers anticipate...
ASPREE’s first study update in Wollongong
Dr Suzanne Orchard and local ASPREE Senior Study Co-ordinator Rosalind (Ros) Whittaker hosted the first ASPREE...
ASPREE-Hearing sub-study team travels
Taking research to the people The ASPREE-Hearing sub-study research team continue their travels around...
ASPREE-Hearing study design for aspirin test
Journal paper describes rationale and design of the new ASPREE hearing sub-study Loss of hearing can have a...
UK study on aspirin and recurrence of a cancer
Late last month saw the launch of an aspirin study called ADD-Aspirin to investigate whether aspirin can be used to...














